DIABETES IN PREGNANCY - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

DIABETES IN PREGNANCY

Description:

PHYSIOLOGICAL CHANGES OF GLUCOSE METABOLISM IN PREGNANCY. Pregnancy is a state of insulin resistance & relative glucose intolerance ... – PowerPoint PPT presentation

Number of Views:126
Avg rating:3.0/5.0
Slides: 21
Provided by: Sony116
Category:

less

Transcript and Presenter's Notes

Title: DIABETES IN PREGNANCY


1
DIABETES IN PREGNANCY
  • DR. SALWA NEYAZI
  • CONSULTANT OBSTETRICIAN GYNECOLOGIST
  • PEDIATRIC ADOLESCENT GYNECOLOGIST

2
PHYSIOLOGICAL CHANGES OF GLUCOSE METABOLISM IN
PREGNANCY
  • Pregnancy is a state of insulin resistance
    relative glucose intolerance
  • This is due to placental production of
    anti-insulin hormones hPL, cotisol, and
    glucagon
  • FBS ??
  • Postprandial glucose ? ?
  • Insulin production ? ? 2 folds in N women
  • Insulin requirements ? ? in diabetic women
  • ?? renal threshold for glucose ? glycosuria

3
DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS
  • Women in whom the criteria of DM are met in
    pregnancy ? include a gp of diabetics who were
    undiagnosed before pregnancy
  • FBS ? gt 7 mmol/L on 2 occasions
  • Or
  • RBS ? gt 11.1 mmol/L on 2 occasions
  • Borderline cases ? GTT ? DM is Dx if FBS ? gt 7
    mmol/L or 2 hrs gt 11.1 mmol/L
  • Impaired glucose tolerance ? 2hrs G 8-11 mmol/L
    with a N FBS

4
EFFECT OF PREGNANCY ON DM
  • Insulin requirement ? ? in pregnancy reaching a
    max at term being at least 2 X the
    pre-pregnancy requirement
  • Pt with diabetic nephropathy ? deterioration in
    renal function with ? in creatinine clearance
    proteinuria
  • ? this deterioration in renal function is
    usually reversed after delivery

5
EFFECT OF PREGNANCY ON DM
  • 2 X ?? in retinopathy
  • ? rapid improvement in glycemic control ?
    worsening retinopathy due to ?? retinal blood
    flow
  • ?? icidence of hypoglycemia
  • Ketoacidosis is rare unless associated with
    hyperemesis, infections, tocolytic
    corticosteroid Rx

6
EFFECTS OF DM ON PREGNANCY
  • ?? incidence of congenital abnormalities
  • The risk is related to the degree of glycemic
    control ? 5 with Hb A1c gt 8
  • ? 25 with Hb A1c gt 10 with ??
    risk
  • of abortions
  • Sacral agenesis, congenital heart defects,
    skeletal abnormalities neural tube defects
  • Perinatal neonatal mortality ?? 2-4 X
  • Unexplained IUFD at term / more in macrosomic
    babies

7
EFFECTS OF DM ON PREGNANCY
  • Macrosomia ? the incidence is ?? with poor
    diabetic control
  • ? not eliminated by tight control
  • ? associated with ?? risk of operative
    delivery, birth trauma, shoulder dystocia
  • Hyperglycemia ? fetal polyuria ? polyhydramnios ?
    PROM, preterm delivery
  • Prematurity pose an added problem as pulmonary
    surfactant production is slightly delayed in
    babies of diabetic mothers

8
EFFECTS OF DM ON PREGNANCY
  • Postnatally, babies are at risk of hypoglycemia
    jaundice
  • ?? risk of PET especially in pt with pre-existing
    hypertension nephropathy where it reaches
    almost 30

9
MANAGEMENT
  • Multidisciplinary team including obstetricians,
    endocrinologists, dieticians, midwives ?
    optimize outcome
  • Preconception councelling
  • To achieve normoglycemia as far as possible
  • ?FBS lt 5 mmol/L
  • ?PP lt 7.5 mmol/L
  • Dietary advice on a low sugar, low fat, high
    fiber diet
  • Regular capillary glucose series (7 point
    profile)
  • Combined short acting intermediate acting
    insulin

10
MANAGEMENT
  • Regular assessment of Hb A1c
  • Ophthalmologic examination Rx of retinopathy
  • Regular monitoring of renal function in Pt with
    diabetic nephropathy
  • Detailed U/S screening for congenital
    malformations in the 2nd trimester (20wk) ? to
    exclude NTD, sacral agenesis, cardiac defects
  • Frequency of antenatal visits needs to be
    individualized

11
ANTENATAL FETAL SURVELANCE
  • ?? incidence of IUFD justify close monitoring in
    the 3rd trimester
  • Serial U/S biometry ? to detect macrosomia,
    hydramnios, IUGR
  • Umbilical artery doppler in Pt with IUGR
  • CTG
  • BPP

12
LABOR DELIVERY
  • With well controlled DM with appropriately grown
    fetus ? pregnancy is allowed to proceed till term
  • When there is concern about fetal well being or
    macrosomia ? the risk of IUFD must be weighed
    against the risk of RDS
  • ½ of the babies are gt90th centile ? CS rate of
    50-60
  • Intrapartum care should focus on meticulous
    diabetic control continuous electronic fetal
    monitoring . Blood glucose should be 4-7 mmol/L
    achieved by 5 Dextrose infusion insulin
    infusion

13
LABOR DELIVERY
  • After delivery mternal insulin requirement
    rapidly returns to the pre-pregnancy level
  • If abnormal glucose tolerance was 1st Dx in
    pregnancy ? GTT should be done 6 wk post-partum

14
Gestational diabetes
  • Carbohydrate intolerance of variable severity 1st
    Dx in pregnancy ? will include women with
    undiagnosed DM
  • There is no consensus on the optimal screening
    for GDM
  • ?Universal screening
  • ?Screening pt gt 25 Y
  • ?Clinical risk factors previous GDM, family Hx ,
    previous macrosomic baby, previous unexplained
    IUFD, obesity, glycosuria, polyhdramnios, LGA in
    current pregnancy
  • ? The timing of screening also contraversal

15
Implications of GDM
  • ? perinatal mortality morbidity but to a lesser
    extent than DM
  • No ? risk of congenital malformations
  • Macrosomia is the main risk factor for adverse
    outcome
  • ? risk of operative deliveries
  • ? incidence of PET
  • Women with GDM have a significantly ? risk of DM
    later in life (50 over 10-15 Y)

16
Management
  • Combined diabetic obstetric approach
  • Initial approach by dietery modification
    including caloric reduction in obese Pt
  • The need for insulin is manifested by persistent
    PP hyperglycemia (7.5-8 mmol/l) or persistant
    fasting hyperglycemia (gt5.5-6 mmol/L)
  • Regular U/S scans to assess fetal growth well
    being
  • Early delivery is not advised unless there is a
    complicating factor

17
Management
  • Intrapartum management
  • ?Depends on whether the pt is on diet control
    alone or on insulin
  • ? Pt on insulin need to be on sliding scale
  • ?Following delivery insulin must be discontinued
  • GTT should be done 6 wks postpartum

18
MACROSOMIA
  • Fetal Wt gt4000-4500 gm regardless of gestational
    age
  • Risks of macrosomia include ? shoulder dystocia,
    erbs palsy, ? 5 min APGAR score, admission to
    NICU obesity later in life
  • Risk factors for the development of macrosomia
  • ? prior HX of macrosomia
  • ?? maternal pre-pregnancy Wt
  • ?excessive Wt gain in pregnancy
  • ?multiparity

19
MACROSOMIA (risk factors)
  • ?male fetus
  • ?gestational age gt40wks
  • ?race
  • ?maternal birth Wt
  • ?maternal Ht
  • ?maternal age
  • ?ve GCT with-ve GTT
  • ?GD, DM

20
MACROSOMIA
  • How macrosomic infants of diabetic mothers differ
    from those without diabetes?
  • How is macrosomia predicted?
  • How does it affect the management of labor
    delivery?
  • When is CS recommended for macrosomia?
  • What is the role of induction of labor?
Write a Comment
User Comments (0)
About PowerShow.com